These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4899118)

  • 21. [Maximal dose of extemporaneous injectabile preparations].
    Rugginenti G; Zorzetto C
    Boll Chim Farm; 1971 Feb; 110(2):57-9. PubMed ID: 5561769
    [No Abstract]   [Full Text] [Related]  

  • 22. Practical considerations in development of solid dosage forms that contain cyclodextrin.
    Miller LA; Carrier RL; Ahmed I
    J Pharm Sci; 2007 Jul; 96(7):1691-707. PubMed ID: 17243148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects.
    Lin X; Hu Y; Liu L; Su L; Li N; Yu J; Tang B; Yang Z
    Pharm Res; 2018 Apr; 35(6):125. PubMed ID: 29687226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs).
    Raw AS; Furness MS; Gill DS; Adams RC; Holcombe FO; Yu LX
    Adv Drug Deliv Rev; 2004 Feb; 56(3):397-414. PubMed ID: 14962589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hot-melt extrusion.
    Jana S; Miloslava R
    Ceska Slov Farm; 2012 Jun; 61(3):87-92. PubMed ID: 22913823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FALLACIES OF GENERIC EQUIVALENCE THESIS. II. PHYSICO-CHEMICAL AND PHARMACEUTIC FACTORS AFFECTING GASTROINTESTINAL ABSORPTION.
    DELGADO JN; COSGROVE FP
    Tex State J Med; 1963 Nov; 59():1106-12. PubMed ID: 14084906
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug safety: the viewpoint of the pharmaceutical manufacturing industry.
    Wigle WW
    Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099
    [No Abstract]   [Full Text] [Related]  

  • 28. Solubility enhancement and solid-state characterisation.
    Tobyn M
    Pharm Dev Technol; 2018 Sep; 23(7):663. PubMed ID: 30106327
    [No Abstract]   [Full Text] [Related]  

  • 29. Alternative and generalized approach to in vitro-in vivo correlation.
    Vitková Z; Vitko A; Zabka M; Cizmárik J
    Acta Pol Pharm; 2011; 68(3):417-21. PubMed ID: 21648197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interdependence of Dosage Form Microstructure and Performance.
    Axel Zeitler J; Rades T
    Pharm Res; 2017 May; 34(5):887-889. PubMed ID: 28299534
    [No Abstract]   [Full Text] [Related]  

  • 32. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and Stability of Solutions.
    Akers MJ
    Int J Pharm Compd; 2016; 20(1):41-5. PubMed ID: 27127830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic Principles of Lyophilization, Part 1.
    Akers MJ
    Int J Pharm Compd; 2015; 19(6):471-6. PubMed ID: 26891561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug product quality.
    J Am Pharm Assoc; 1970 Feb; 10(2):107-16. PubMed ID: 5411068
    [No Abstract]   [Full Text] [Related]  

  • 36. Stability and in vitro release profile of enalapril maleate from different commercially available tablets: possible therapeutic implications.
    Lima DM; dos Santos LD; Lima EM
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):934-7. PubMed ID: 18472382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biopharmaceutical classification system--experimental model of the prediction of drug bioavailability].
    Golovenko NIa; Borisiuk IIu
    Biomed Khim; 2008; 54(4):392-407. PubMed ID: 18988456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the electrokinetic properties on the stability of mebendazole suspensions for veterinary applications.
    Cózar-Bernal MJ; Gallardo V; Sáez-Fernández E; Holgado MA; Alvarez-Fuentes J; Fernández-Arévalo M; Arias JL
    Int J Pharm; 2010 Jun; 393(1-2):161-6. PubMed ID: 20435113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug dosage form and action].
    Zathurecký L
    Med Klin; 1974 Apr; 69(16):667-70. PubMed ID: 4837397
    [No Abstract]   [Full Text] [Related]  

  • 40. Microenvironmental pH modulation in solid dosage forms.
    Badawy SI; Hussain MA
    J Pharm Sci; 2007 May; 96(5):948-59. PubMed ID: 17455349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.